Pharmaceutical Supply of Lidocaine Hydrochloride and Epinephrine Injection

The contract pertains to the supply and delivery of FDA-regulated Lidocaine Hydrochloride and Epinephrine Injection, USP, in 50-cartridge units, with a guaranteed minimum shelf life of 13 months at the time of delivery. All products must comply with hazardous material labeling requirements to ensure safe handling, transportation, and storage in accordance with federal regulations. The injection is intended for medical use and must meet stringent quality and safety standards associated with pharmaceuticals regulated by the Food and Drug Administration. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with the place of performance designated as FPO, ZIP 96674. The solicitation was posted on July 16, 2026, and responses are due by July 22, 2026, indicating a tight turnaround period for potential suppliers. The NAICS code 325412 identifies the industry as Pharmaceutical Preparation Manufacturing, underscoring the specialized nature of the product. The contract is accessible via the DIBBS platform and requires strict adherence to regulatory and logistical specifications to fulfill performance obligations.